ULCERATIVE COLITIS (UC)
Clinical trials for ULCERATIVE COLITIS (UC) explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS (UC) trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS (UC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for ulcerative colitis: drug shows promise in early trial
Disease control CompletedThis study tested a new drug called IBI112 in 150 people with moderate to severe ulcerative colitis, a condition that causes inflammation and sores in the colon. The goal was to see if IBI112 could help patients achieve remission (no symptoms) after 12 weeks of treatment. Partici…
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New IBD drug shows promise in Real-World study
Disease control CompletedThis study tested VedAryo® (vedolizumab) in 150 people with inflammatory bowel disease (Crohn's disease or ulcerative colitis). The goal was to see if the drug safely reduces symptoms over 52 weeks. Participants received the drug and were monitored for side effects and improvemen…
Matched conditions: ULCERATIVE COLITIS (UC)
Sponsor: AryoGen Pharmed Co. • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Can a smartphone app and a book reduce disability from Crohn's and colitis?
Symptom relief CompletedThis completed study tested whether four free self-help resources—a symptom-tracking app, a cognitive behavioral therapy workbook, a helpline, and a peer mentor—could help adults with moderate-to-severe IBD disability. Over 800 participants were randomly assigned to different com…
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 22, 2026 11:59 UTC
-
Gene clues may predict ulcerative colitis treatment success
Knowledge-focused CompletedThis study looked at whether differences in the IL-7R gene are linked to getting ulcerative colitis (UC) and how well patients respond to the drug vedolizumab. Researchers compared 898 people with UC and healthy controls. The goal is to better understand who might benefit most fr…
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC